Back

SGLT2 inhibitors in HFmrEF and HFpEF: fulfilling an unmet need?

21 May 2022 (14:21 - 14:33)
Organised by:
Congress Presentation Part of: SGLT2 inhibitors across the spectrum of heart failure Chronic Heart Failure HFA Premium Access Heart Failure 2022

About the speaker

Photo
Professor Mark C Petrie

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
Decoding cardio-protection with SGLT2 inhibitors: new insights into cardio-renal mechanisms.
Professor P. Seferovic (Belgrade, RS)
Slides Video
Presentation thumbnail
SGLT2 inhibitors: major cardiovascular outcomes in ambulatory patients with HFrEF.
Professor G. Rosano (London, GB)
Slides Video
Presentation thumbnail
SGLT2 inhibitors in worsening and decompensated heart failure: a promising perspective.
Professor P. Ponikowski (Wroclaw, PL)
Slides Video
Presentation thumbnail
SGLT2 inhibitors across the spectrum of heart failure - discussion.
Video

Access the full session

Session thumbnail
SGLT2 inhibitors across the spectrum of heart failure
Video

The Event

Event poster

Heart Failure 2022

21 May 2022 14:21 CET
You may be interested in
thumbnail
Congress Session
Bridging gaps in heart failure care: primary care trends, exercise, kidney function, and global health perspectives
thumbnail
Congress Session
Nursing and Allied Professions Investigator Award
thumbnail
Congress Session
Which device might help your HFpEF patient?